MD2551G2 - Use of pharmaceutically acceptable ozonized solutions for treatment of oral cavity mycoses - Google Patents
Use of pharmaceutically acceptable ozonized solutions for treatment of oral cavity mycosesInfo
- Publication number
- MD2551G2 MD2551G2 MDA20030280A MD20030280A MD2551G2 MD 2551 G2 MD2551 G2 MD 2551G2 MD A20030280 A MDA20030280 A MD A20030280A MD 20030280 A MD20030280 A MD 20030280A MD 2551 G2 MD2551 G2 MD 2551G2
- Authority
- MD
- Moldova
- Prior art keywords
- mycoses
- treatment
- pharmaceutically acceptable
- oral cavity
- ozonized
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention refers to medicine, in particular to stomatology.Summary of the invention consists in using pharmaceutically acceptable ozonized solutions for treatment of oral cavity mycoses.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDA20030280A MD2551G2 (en) | 2003-12-03 | 2003-12-03 | Use of pharmaceutically acceptable ozonized solutions for treatment of oral cavity mycoses |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDA20030280A MD2551G2 (en) | 2003-12-03 | 2003-12-03 | Use of pharmaceutically acceptable ozonized solutions for treatment of oral cavity mycoses |
Publications (1)
Publication Number | Publication Date |
---|---|
MD2551G2 true MD2551G2 (en) | 2005-03-31 |
Family
ID=62129620
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MDA20030280A MD2551G2 (en) | 2003-12-03 | 2003-12-03 | Use of pharmaceutically acceptable ozonized solutions for treatment of oral cavity mycoses |
Country Status (1)
Country | Link |
---|---|
MD (1) | MD2551G2 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2123319C1 (en) * | 1996-12-24 | 1998-12-20 | Нижегородская государственная медицинская академия | Method of treating inflammatory diseases of parodontium |
MD2354F1 (en) * | 2003-07-29 | 2004-01-31 | Boris Pirgari | Method of treatment of the hepatic encephalopathy |
MD2375F1 (en) * | 2003-07-29 | 2004-02-29 | Constantin Tibirna | Method of portal gastropathy treatment in hepatic cirrhosis |
MD2327G2 (en) * | 2003-07-11 | 2004-07-31 | Андрей ПЫРГАРЬ | Method of treatment of parodontium affections |
-
2003
- 2003-12-03 MD MDA20030280A patent/MD2551G2/en not_active IP Right Cessation
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2123319C1 (en) * | 1996-12-24 | 1998-12-20 | Нижегородская государственная медицинская академия | Method of treating inflammatory diseases of parodontium |
MD2327G2 (en) * | 2003-07-11 | 2004-07-31 | Андрей ПЫРГАРЬ | Method of treatment of parodontium affections |
MD2354F1 (en) * | 2003-07-29 | 2004-01-31 | Boris Pirgari | Method of treatment of the hepatic encephalopathy |
MD2375F1 (en) * | 2003-07-29 | 2004-02-29 | Constantin Tibirna | Method of portal gastropathy treatment in hepatic cirrhosis |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA04003666A (en) | Use of flibanserin in the treatment of sexual disorders. | |
ZA200606173B (en) | Effervescent oral opiate dosage form | |
TW200505881A (en) | Tri(cyclo) substituted amide compounds | |
IL171974A0 (en) | Tetrahydrocarbazole derivatives and their pharmaceutical use | |
TW200500358A (en) | Compounds | |
PL1654253T3 (en) | Substituted 3-pyrrolidin-indole derivatives | |
EA200702522A1 (en) | SYSTEM OF DELIVERY OF MEDICINES IN THE CAVITY OF THE MOUTH AND METHODS OF ITS APPLICATION | |
WO2002088100A3 (en) | Deuterated 3-piperidinopropiophenone and medicaments containing said compounds | |
HRP20041092A2 (en) | New pharmaceutical compositions containing filbanserin polymorph a | |
IL175303A0 (en) | Oral formulations for 5-ht-receptor agonists, uses and methods of treatment employing the same | |
WO2005082413A3 (en) | Ciclesonide and glycopyrronium combination | |
GR20020100478A (en) | Anhydrous crystalline valaciclivier hydrochloride | |
AU2003272317A1 (en) | Treatment of periodontal disease with photosensitizers | |
UA83821C2 (en) | Benzenesulphonamide derivatives, method for production and use thereof for treatment of pain | |
MXPA05014184A (en) | Use of hyaluronic acid for preparing compositions for treating oral cavity aphthas. | |
UA85685C2 (en) | Use of quinolone antibiotics for controlling bacterial diseases of oral cavity | |
RS20050835A (en) | Compositions of buccal dosage forms for extended drug release and the process of preparing such compositions | |
TW200503785A (en) | Dosage form containing (S)-pantoprazole as active ingredient | |
MX260260B (en) | Semi-solid formulations for the oral administration of taxoids. | |
EG24959A (en) | Indoles useful in the treatment of androgenreceptor related diseases. | |
MD2551G2 (en) | Use of pharmaceutically acceptable ozonized solutions for treatment of oral cavity mycoses | |
MXPA05007253A (en) | Novel anticonvulsant derivative salts. | |
PL371269A1 (en) | 1-phenyl-2-heteroaryl-substituted benzimidazole derivatives, the use thereof for producing drugs used in the treatment of immunological diseases | |
UA90843C2 (en) | Tri(cyclo) substituted amide compounds | |
GB0128071D0 (en) | Medicament |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
MM4A | Patent for invention definitely lapsed due to non-payment of fees |